Table 1.
Reference | Number and species | Protocol | Type and route | Dose | Number of L-asp prescribed | Number and type of HSR | Percent reaction |
---|---|---|---|---|---|---|---|
20 | 1 dog | Adria/DTIC, L-asp, vaccine | Native IP | 20 000 IU/m2 | 3 | 1 total: death | Case report |
10 | 62 dogs | L-asp maintenance | PEG IM vs native IP | 400 IU/kg BW | Until relapse | 12 total: all native IP; 9 shock, 3 angioedema | 19.3% |
15 | 69 dogs | L-asp maintenance | PEG IM vs native IM | 400 IU/kg BW | Until relapse | 3 total: 1 PEG: urticaria, 2 native: 1 limb edema & 1 shock, seizures | 4.3% |
16 | 68 dogs | ACOPA ll | Native IM | 10 000 IU/m2 Max 10 000 IU |
4 | 4 total: 3 collapse, 1 angioedema | 5.8% |
17 | 98 dogs | VELCAP-L | Native IM | 10 000 IU/m2 | 5 | 5 total | 5.1% |
18 | 82 dogs | VELCAP-S | Native IM | 10 000 IU/m2 Max 10 000 IU |
5 | 6 total | 7.3% |
19 | 93 dogs | VELCAP-SC | Native SQ | 10 000 IU/m2 Max 10 000 IU |
2 | 4 total | 4.3% |
8 | 48 dogs | Lomustine, L-asp, pred rescue | Native IM or SQ | 400 IU/kg BW | Until relapse | 5 total: all SQ; 3 grade l, 2 grade 2, vomiting, facial swelling, urticaria | 10.4% |
6 | 66 dogs | L-CHOP +/− CCNU, MOPP | Native SQ | 400 IU/kg BW | 2 | 2 total | 3.0% |
9 | 36 cats | L-asp rescue | Native IV, then IP | 400 IU/kg BW | Until relapse | 1 total | 2.7% |
BW — body weight.